FEINBERG LARRY N 13D and 13G filings for Pacific Biosciences of California, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-24 4:20 pm Sale | 2022-02-18 | 13G | Pacific Biosciences of California, Inc. PACB | FEINBERG LARRY N | 3,257,503 4.970% | -370,046 (-10.20%) | Filing |
| 2022-02-11 4:04 pm Sale | 2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | FEINBERG LARRY N | 3,627,549 5.530% | -178,590 (-4.69%) | Filing |
| 2021-02-16 4:02 pm Sale | 2020-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | FEINBERG LARRY N | 3,806,139 6.670% | -890,513 (-18.96%) | Filing |
| 2020-02-14 4:08 pm Sale | 2019-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | FEINBERG LARRY N | 2,004,688 4.810% | -42,970 (-2.10%) | Filing |
| 2020-02-14 4:07 pm Sale | 2019-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | FEINBERG LARRY N | 4,696,652 8.590% | -114,870 (-2.39%) | Filing |